StockData

Quest Diagnostics vs Fortrea

DGX and FTRE side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DGX and FTRE compare

Quest Diagnostics is the larger company, worth 15 times as much as Fortrea ($28.2B against $1.9B).

Quest Diagnostics grew revenue faster over the last twelve months (9.1% versus −3.4% for Fortrea).

Quest Diagnostics keeps more of each dollar of sales as profit, with a net margin of 9.5% compared with −2.6% at Fortrea.

Quest Diagnostics pays a dividend yielding 1.3%; Fortrea does not pay one.

Quest Diagnostics scores higher on the StockData Score (12 against 4 for Fortrea), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDGXFTRE
Size and price
Market cap$28.2B$1.9B
Share price$256.35$19.59
Change, 1 year37.1%88.2%
Change, 5 years65.4%–
Beta (5Y)−0.371.30
Employees57K14K
StockData Score
Total score12 (better)4
Valuation score00
Growth score22
Performance score4 (better)2
Health score3 (better)0
Dividend score3 (better)0
Valuation
P/E25.6×–
P/S2.4×0.7× (better)
P/B3.7×3.6× (better)
EV/EBITDA14.4× (better)29.8×
P/FCF20.5×11.2× (better)
PEG8.08–
FCF yield4.9%8.9% (better)
Fair value$236.67$12.57
Margin of safety−8.3% (better)−55.9%
Growth
Revenue growth (TTM)9.1% (better)−3.4%
Revenue growth, 5Y average3.2%–
Net income growth (TTM)16.5%–
EPS growth (TTM)18.3%–
EPS growth, 5Y average−3.5%–
Profitability
Gross margin33.1% (better)20.0%
Operating margin14.6% (better)0.48%
Net margin9.5% (better)−2.6%
FCF margin11.6% (better)6.3%
Return on equity15.2% (better)−12.3%
Return on invested capital10.7% (better)0.69%
Financial health
Debt / equity0.73 (better)1.98
Net debt / EBITDA2.06 (better)9.12
Current ratio1.70 (better)0.97
Altman Z-score3.79 (better)0.76
Piotroski F-score7 (better)3
Dividends and buybacks
Dividend yield1.3%–
Payout ratio32.7%–
Shareholder yield1.3% (better)0.00%
Ownership
Held by institutions95.4%104%
Held by insiders0.48%3.9%
Insider net buying, 12 months−$36.5M−$4.7M (better)
Superinvestors holding1–
Short interest, % of float3.4%9.2%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.